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CD29Themigration ofmesenchymal stemcells (MSCs) plays a key role in tumor-targeted delivery vehicles and tumor-
related stroma formation. However, there so far has been no report on the distribution of cell surface molecules
during the VEGF-induced migration of MSCs. Here, we have utilized near-ﬁeld scanning optical microscopy
(NSOM) combined with ﬂuorescent quantum dot (QD)-based nano-technology to capture the functional rela-
tionship between CD44 and CD29 adhesionmolecules onMSCs and the effect of their spatial rearrangements. Be-
fore VEGF-induced migration of MSCs, both CD44 and CD29 formed 200–220 nm nano-domains respectively,
with little co-localization between the two types of domains. Surprisingly, the size of the CD44 nano-domain rap-
idly increased in size to 295 nm and apparently larger aggregates were formed following MSC treatment with
VEGF for 10 min, while the area of co-localization increased to 0.327 μm2. Compared with CD44, CD29 was acti-
vated obviously later, for the fact that CD29 aggregation didn't appear until 30min after VEGF treatment. Consis-
tently, its co-localization area increased to 0.917 μm2. The CD44 and CD29 nano-domains further aggregated into
larger nano-domains or even formed micro-domains on the membrane of activated MSCs. The aggregation and
co-localization of these molecules promoted FAK formation and cytoskeleton rearrangement. All of the above
changes induced byVEGF contributed toMSCmigration. Taken together, our data of NSOM-based dual colorﬂuo-
rescent imaging demonstrated for theﬁrst time that CD44, togetherwith CD29, involved inVEGF-inducedmigra-
tion of MSCs through the interaction between CD44 and its co-receptor of VEGFR-2.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Mesenchymal stem cells (MSCs) have the ability to self-renew and
can be isolated and expanded from bone marrow and other tissues.
MSCs that are positive for the markers CD105, CD90, CD73, CD44,
CD166 and CD29 aremulti-potent progenitors for several mesenchymal
lineages, including osteoblasts, chondrocytes, adipocytes,myotubes and
hematopoietic-supporting cells [1–3]. The ability of MSCs to self-renew
and differentiate makes them a promising tool for clinical applications
in regenerative medicine and tissue engineering [4–8]. The building of
new blood vessels, or neovascularization, is a primary concern in a
wide range of diseases. For example, area of interest in which MSCs
are actively being studied is in the treatment of myocardial infarctions.
To repair the region of infarction, MSCs must travel from the injection
point to reach the target area [7,9–12]. Therefore, the common hypoth-
esis is thatMSCs possessmigratory activity. Indeed, it has been reported
that cytokines can stimulateMSCmigration and support the potential of
MSCs as tumor-targeted delivery vehicles for therapeutic agents by
making use of these cytokines from tumors [13–16]. There is ampleevidence to suggest thatMSCs can be recruited to the location of tumors
and can contribute to tumor-related stroma formation [2,17–21]. In ad-
dition, a number of studies have found thatMSCs canmigrate to regions
of gastric carcinoma, melanoma, multiple myeloma and breast cancer
[2,15,18,22].
Since directedmigration ofMSCs has important roles in both tumor-
related stroma formation and in the role of MSCs as tumor-targeted
delivery vehicles for therapeutic agents, understanding the precise
mechanism underlying the tropism of MSCs induced by tumors has
been an area of active study in recent years. For example, directed
migration of MSCs to tumor sites can be mediated by several tumor-
derived cytokines, including monocyte chemotactic protein-1 (MCP-1)
[13], platelet derived growth factor [14], matrix metalloproteinase 1
[23] chemokine CCL25 [15], vascular endothelial growth factor (VEGF)
[24], and basic ﬁbroblast growth factor (FGF-basic) [7]. Among these
cytokines, VEGF seems to be particularly important in enhancing and
directing human MSC motility [7,25,26]. Although these views are
conﬁrmed by traditional method of biology, little is known about the
speciﬁc molecular mechanisms involved in the VEGF-induced directed
migration of MSCs.
Most recently, Aldridge et al. [27] reported that hMSCs migrate to
liver tissues and endothelium and bind in greater numbers in disease
conditions regulated by CD29 and CD44 in vitro and in vivo. CD29
Fig. 1. A schematic diagram of experimental setup. Mesenchymal stem cells are seeded in
a culture dish with a VEGF concentration gradient.
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mediating adhesion between the cell and the extracellular matrix.
CD44 class I transmembrane glycoproteins are adhesion molecules in-
volved in cell–cell and cell–substrate interactions. Some studies suggest
that CD44 plays a key role in cytoskeletal rearrangement [28], takes part
in a CD44–Src–integrin signaling axis in lipid rafts [29], andmost impor-
tantly, CD44 can be a co-receptor of VEGFR-2 [30]. Direct visualization of
the spatial distribution of CD29 and CD44 on the cell membrane and
their changes during MSC activation with VEGF may help to elucidate
the molecular mechanisms underlying the directional migration of
MSC. However, these types of molecular imaging studies have not
been reported.
Variousmethods have been employed to visualize the cell surface at
nanometer scale resolution. For example, scanning tunnelingmicrosco-
py (STM) can be used to visualize the cell surface at the highest resolu-
tion, but sample preparation can be complex. Atomic force microscopy
(AFM) is limited for failing to obtain speciﬁc ﬂuorescence information
for naturally unknown molecules on cell surface. Laser scanning
confocal microscopy does not provide sufﬁciently high resolution for
the detection of cell membrane ﬂuctuations and cell surface molecules
at a nanometer scale [31]. Stimulated emission depletion (STED) and
photoactivatable localization microscopy (PALM) lack simultaneous to-
pographic information [32]. In contrast, NSOM is a microscopic tech-
nique where a sub-wavelength-sized aperture probe is raster scanned
very close (b10 nm) to the sample, providing simultaneous optical
and topographic lateral resolution beyond the diffraction limit of light
[33]. Moreover, quantum dots (QDs) are a new class of ﬂuorescent
markers for immunoﬂuorescent labeling and possess very high levels
of brightness and photo-stability. As such, NSOM used in conjunction
with QDs is the best technique by which the distribution of membrane
receptors can be measured at the nanometer scale [31–37]. In this
study, our results indicate that VEGF can induce directed migration of
MSCs through the formation of (focal adhesion kinase) FAK and cyto-
skeletal rearrangements. To determinewhether directedMSCmigration
is based on these adhesion molecules, we have developed the a NSOM/
QDs-based nanotechnology using dual-color imaging to visualize the
nanometer scale distribution and organization of CD44 and CD29, as
well as their spatial organization on the cell surface. We found that
VEGF can induce CD44 and CD29 molecules to form large clusters and
much more CD44 molecules colocalize with CD29. This novel imaging
approach that has made it possible to visualize the nano-spatial distri-
bution and organization of CD44 and CD29 on MSCs may help explain
the molecular mechanism behind the directional migration of MSCs
induced by VEGF.
2. Materials and methods
2.1. Isolation and culture of MSCs
MSCswere prepared in a similarmanner to themethod described by
Weiss et al. [38]. Brieﬂy, umbilical cords were collected and processed
within 12 h after normal births. Umbilical arteries and vein were re-
moved, and the remaining tissue was transferred to a sterile container
in Dulbecco's modiﬁed essential media (DMEM) containing antibiotics
(penicillin 100 mg/ml, streptomycin 10 mg/ml, and amphotericin B
250mg/ml) and cut into small fragments. The explantswere transferred
to 6-well plates containing DMEM supplemented with 20% fetal bovine
serum. After a week, when well-developed colonies of ﬁbroblast-like
cells appeared, cultures were harvested with 0.05% trypsin and pas-
saged onto sterilized coverslips and kept in a 6-well plate for 2–3 days.
2.2. Preparation of methyl cellulose dish (MCD)
One percent methyl cellulose (Sigma, M-0512) was dissolved with
distilled water and sterilized in a high pressure sterilization pot. Three
hundred microliters of 1% sterile methyl cellulose was added to moldconcave hole and dried on a laminar ﬂow cabinet. Finally, the methyl
cellulose membrane was prepared and placed in aseptic petri dishes
for later use.
2.3. Sample preparation
The above preparedMCDswere placed on one side of the cell culture
dish, as shown in Fig. 1, while the coverslipwith cellswere placed on the
other side of the cell culture dish (an experimental group injected with
300 μl of 50 ng/ml VEGF into the MCD, another control group injected
with 300 μl of PBS). Upon adding medium, VEGF could diffuse in a
gradient in the dish. After the cells were incubated for 24 h at 37 °C in
a 5% CO2 incubator, MSCs grown on the sterile coverslip were ﬁrst
washed three times with PBS buffer, then ﬁxed with 4% formaldehyde
at room temperature for 15 min and washed another three times with
PBS prior to incubating with monoclonal antibodies (mAbs),
phalloidin–FITC, and anti-human FAK.
2.4. Dual-color immunoﬂuorescence labeling
Dual-color immunoﬂuorescence labeling for mAbs and QD
conjugates was performed according to the methods described by
Chen et al. [31,32] with slight modiﬁcations. Brieﬂy, the cells were
blocked for 60 min with 6% bovine serum albumin to rule out non-
speciﬁc adsorption of biotin-CD29. The cells were incubated with
20 μg/ml biotinylated anti-human CD29 antibody for 60 min, washed
three times with PBS to remove unbound CD29, followed by incubation
with 1 μg/mlQD655 (red light emitting)-streptavidin for 60min. For the
second color labeling, we used 200 μg/ml biotin to block residual avidin
sites on the surface of QDs before repeating the CD29 protocol with the
CD44 antibody. CD44 labeling used QD565 (green light emitting)-
streptavidin so that it could be distinguished from CD29. The samples
destined for laser scanning confocal microscopy (LSCM) were washed
three times with PBS to remove any unbound QDs and mounted on a
glass slide with 30% glycerol. The samples used for NSOMwere washed
three times with dd water to remove any QDs and salt particles on the
cells.
2.5. NSOM imaging
An Aurora-2 NSOM system (Veeco) was used in this study. The
system was shown schematically in our pervious study [34]. The sam-
ples are mounted on the XY stage with a full scanning range of
30 μm× 30 μm, and a video camera was used to locate the region of in-
terest. The excitation light came from a DPSSL laser (457 nm, Chang-
chun Photoelectric Inc., Jilin, China) coupled with an Al-coated tapered
ﬁber probe with an aperture diameter of approximately 50 nm. The
probe tip was attached to a piezoelectric quartz tuning fork (resonance
frequency of approximately 93 kHz), and the probe–sample distance
was maintained constantly at 10 nm by tuning-fork-based shear-force
feedback. This mode of operation provided simultaneous topographic
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(Olympus Corp., Tokyo, Japan). The collected light was ﬁltered at 565±
10 nm for QD565 and 655 ± 10 nm for QD655 using a Liquid Crystal
Tunable Filter (VariSpec, CRI, Inc.) to separate the ﬂuorescence emission
from the excitation light. Our previously data indicated that QDs exhibit
a relatively homogeneous spreadwith amean size (measured at the full
width at half maximum, FWHM) of 50 nmwhich is a result of the con-
volution effect of the probe (the diameter of QD605-streptavidin is
~20 nm according to the vendor), indicating that NSOM probes were
able to generate nanoscale images of the QDs and that the 50-nm dots
corresponded to single QDs [32]. These results suggest that QD-based
NSOM imaging may be suitable for single molecule detection on the
cell surface. In this study, the laser excitation intensity was approxi-
mately 200 W/cm2 and all images consisted of 300 × 300 measured
points.
2.6. LSCM imaging
Focal adhesion formations and cytoskeletal dynamics were evaluat-
ed by labelingwith anti-FAK and FITC–phalloidin.MSCswith orwithout
VEGF stimulation were incubated separately with 50 mM anti-FAK and
1 mM FITC–phalloidin for 60 min in the dark at room temperature.
After, cellswerewashed twicewith PBS. Then, focal adhesion formation,
cytoskeletal organization, and the localization of CD44 and CD29 were
imaged by a LSCM (LCM 510 Meta Duo Scan, Carl Zeiss, and Germany).
2.7. AFM imaging
MSCs incubated with or without VEGF for 24 h were ﬁxed with 2.5%
glutaraldehyde for 10 min. Cells on 24-well plates were washed with
distilledwater three times and air-dried at room temperature. The sam-
ple was mounted onto the XY scanning station with a max scanning
range of 100 μm × 100 μm and observed at room temperature by AFM
(Autoprobe CP Research, Thermomicroscopes, Veeco Instruments Inc.)
in contact mode. The spring constant of the Si3N4 cantilevers
(Microlever; Park Scientiﬁc Instruments) and the radius of curvature
of the tips were 2.8 N/m and 10 nm respectively. All of the acquired
images (256 pixel × 256 pixel) were ﬂattened by the provided software
(IP 2.1) to eliminate background noise at low frequency in scanning
direction (ﬂattening order: 0–1).
2.8. Migration of MSCs
To analyze themigration ofMSCs, we performed thewound-healing
migration assay. The assay was performed as described previously [39].
Brieﬂy, MSCs were plated onto the 24-well plates which were then
cultured overnight at 37 °C in a 5% CO2 incubator. After reaching 80%,
conﬂuence MSCs were starved to inactivate cell proliferation and a
scratch was made on the cell layer using a pipette tip. DMEM-F12
containing 0.5% FBS was added in the presence or absence of VEGF.
The open wound surface area was quantiﬁed with an inverted phase-
contrast microscope following 0, 1, 6, 12 and 24 h incubation. All exper-
iments were repeated at least three times.
2.9. Data processing and statistics
Confocal microscopic images were processed using Zeiss LSM soft-
ware (Carl Zeiss, Germany). The NSOM data was processed by the
SPMLab 5.0.1 software (Veeco, Santa Barbara, CA). The size of a ﬂuores-
cent spot was deﬁned by the maximum distance between two pixels
within the contour of each spot. The intensity of each spot was deﬁned
by the sum of the intensity over all pixels within the contour of the spot.
The 2-dimensional merged image of two color ﬂuorescence images was
generated using Image J. Fluorescence statistics were analyzed in a
semiautomated fashion using custom-written software based on
Matlab 6.5 (The Mathworks Inc., Natick, MA) and Visual C++ 6.0(Microsoft Corp., Redmond, WA). SPSS 11.02 (SPSS Inc., Chicago, IL)
was used to create histograms.
3. Results
3.1. Inverted microscope images of MSCs
To conﬁrm the effect that a concentration gradient of VEGF has on
the migration of MSCs, we used an inverted microscope to observe
changes in MSC morphology at the macroscopic scale. As shown in
Fig. 2A, most MSCs in the control group had a regular spindle shape
indicating that they were well-spread on the coverslip and appeared
randomly oriented. The cell density was also rather low. However, in
the presence of a VEGF gradient, the cell density increased greatly,
indicating that a large number of MSCs had proliferated. Moreover,
the vast majority of MSCs had a long spindle shape and were preferen-
tially distributed toward the top left corner, where theMCDwas located
(Fig. 2B). These results indicate that MSCs were migrating to the loca-
tion of the MCD.
3.2. LSCM imaging of CD29 and CD44 molecules
We wanted to ﬁnd out whether directed migration in MSCs is
related to the two important adhesion molecules, CD44 and CD29. For
this purpose, QD-based ﬂuorescence dual-color labeling technology
was used to visualize the distribution of CD29 and CD44 molecules on
MSCs in the presence or absence of VEGF stimulation for either 30 min
or 24h.GreenﬂuorescenceQDswere used to label CD44,while redﬂuo-
rescence QDs were used for CD29, and their locations on the cell were
measured by LSCM (Fig. 3). Yellow ﬂuorescence indicates colocalization
of CD44 and CD29.
In the control group (Fig. 3A), CD44 was uniformly distributed over
the cell surface and granular ﬂuorescence could be observed. A large
number of CD29 molecules were located at the edge of MSCs while a
few molecules could be found on the top of cells. The merged images
of CD29 and CD44 show faint colocalization.
At 30min post-VEGF stimulation, the distribution of CD44 and CD29
(Fig. 3B) was not signiﬁcantly different when compared with the con-
trol group. However, after VEGF-stimulation for 24 h (Fig. 3C), the
growth of MSCs trended toward a speciﬁc direction, consistent with
the results observed by an inverted microscope. The distribution of
CD44 and CD29 also showed signiﬁcant changes. Fig. 3C shows that,
both CD44 and CD29 appeared as larger ﬂuorescent spots. To compare
their ﬂuorescence intensity with the control group and the 30min stim-
ulation group, the LSCM detector gain was increased approximately
20%. These results suggest that the expression level of CD44 and CD29
was increased with increased stimulation time with VEGF. At the
same time, the area of colocalization between CD44 and CD29 mole-
cules was also increased. In order to further study the distribution and
colocalization of CD44 and CD29, we used the “digital zoom” function
of LSCM to enlarge the white boxed area shown in Fig. 3C (top right),
and the enlarged region is shown in the lower panel of Fig. 3C. In
these zoomed-in regions, larger CD44 clusters and areas of CD29 aggre-
gation, as well as colocalization between the two adhesion molecules
were more clearly visible.
3.3. In situ NSOM/QD-based dual color ﬂuorescence imaging of CD44 and
CD29 on VEGF-stimulated MSCs
As the inter-molecular distances between CD44 and CD29 are too
small to be resolved by confocal imaging, we were unable to map the
nanometer scale distribution of these two membrane proteins.
Therefore, we performed in situ NSOM/QD-based nanoscale ﬂuores-
cence imaging of CD44 and CD29 to verify the results obtained by LSCM.
Fig. 4a shows the NSOM image of control MSCswith CD44 labeled in
green (Fig. 4aB) and CD29 labeled in red (Fig. 4aC). The large-scale near-
Fig. 2. Inverted microscope images of MSCs. (A) Control group and (B) induction group by VEGF for 24 h.
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separated domains that are randomly distributed across the cell surface.
In order to quantitatively investigate the spatial organization of CD44Fig. 3. Fluorescent images of CD44 and CD29 acquired by LSCM. A, ControlMSCswithout VEGF s
surfaced stained with anti-CD44 antibody (QD565, green) and anti-CD29 antibody (QD655, red
cence indicates co-localization.and CD29 molecules, the physical sizes of all the ﬂuorescent spots in
Fig. 4aB and C were calculated. The sizes of the 53 ﬂuorescent spots in
Fig. 4aB (CD44) ranged from 70 nm to nearly 330 nm, with an averagetimulation; B and C,MSCs stimulatedwith VEGF for 30min and 24 h respectively. Cells are
). The right panel is themerged image showing overlayed CD44 and CD29. Yellow ﬂuores-
Fig. 4. In situ NSOM/QD-based dual color ﬂuorescence imaging inMSCs induced by VEGF for 30 min. a, Control MSCs; b and c, NSOM images ofMSCs after stimulation by VEGF for 10 min
and 30min respectively. (A) Topographic images of the cell surface. (B) Near-ﬁeld ﬂuorescence images of CD44 labeled using QD565. (C) Near-ﬁeld ﬂuorescence images of CD44 labeled
using QD655. (D) Superimposition of (B) and (C), yellow indicates colocalization between CD44 and CD29. (E) The marked area in (D) is magniﬁed by B-spline interpolation. Few CD44
molecules colocalize with CD29 in the merged image (a). As VEGF stimulation time increased, both CD44 and CD29 formed nanodomains or even microdomains (N500 nm) and
colocalization increased between the two molecules (c). d, Histograms of the frequency distribution of all the CD44 and CD29 ﬂuorescent spots, blue: control group; green: 10 min
VEGF stimulation; and red: 30 min VEGF stimulation.
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(CD29) ranged from less than 100 nm to 350 nm, with an average value
of about 230 ± 130 nm. Fig. 4aD is a superimposed image consisting of
(B, C) and (E) the marked area in (D) was magniﬁed by B-spline inter-
polation. Itwas observed thatmost CD44 andCD29moleculeswere ran-
domly scattered on the cell surface and co-localization rarely occurred
between CD44 and CD29.
Fig. 4b shows the MSCs that have been stimulated with VEGF for
10 min. CD44 was labeled green (Fig. 4bB) and CD29 was labeled red
(Fig. 4bC). Fig. 4bA is a topographic image of the cell. Some small
pseudopodia could be seen around the edge of the cell. The sizes of 42
ﬂuorescent spots in Fig. 4bB (CD44) ranged from 163 nm to nearly
427 nm, with an average value of about 295 ± 132 nm. The sizes of
96 ﬂuorescent spots in Fig. 4bC (CD29) ranged from 120 nm to
408 nm, with an average value of about 264 ± 144 nm. The area of
co-localization between CD44 and CD29 was 0.327 μm2.
Fig. 4c shows the NSOM image of MSCs stimulated with VEGF for
30 min. CD44 was labeled green (Fig. 4cB) and CD29 was labeled red
(Fig. 4cC). Compared with the topographic images of the cell in
Fig. 4aA and Fig. 4bA, there was a signiﬁcant increase in the number ofpseudopodia of the cell in Fig. 4cA. The sizes of 33 ﬂuorescent spots in
Fig. 4cB (CD44) ranged from 153 nm to nearly 505 nm, with an average
value of approximately 329± 176 nm. The sizes of 48 ﬂuorescent spots
in Fig. 4cC (CD29) ranged from 153 nm to 467 nm, with an average
value of approximately 310 ± 157 nm. The area of co-localization be-
tween CD44 and CD29 increased to 0.917 μm2 (Fig. 4cD and Fig. 4cE).
Therefore, the average sizes of CD44 and CD29 spots increased with
the increasing VEGF stimulation, while the area of co-localization be-
tween CD44 and CD29 also increased from 0.327 μm2 to 0.917 μm2.
Aside from calculating the physical size of the ﬂuorescent spots, we
also analyzed the ﬂuorescent intensity of these spots. Histograms of
the frequency distribution of CD44 and CD29 ﬂuorescence intensities
are shown in Fig. 4dG and H. In Fig. 4dG, the intensity of ﬂuorescent
spots from CD44 (two cells, 130 ﬂuorescent spots) was less than
2000 mV in the control group (blue histogram). After MSCs were
stimulated for 10 min with VEGF, the intensity of more than 30% of
the ﬂuorescent spots (two cells, 101 ﬂuorescent spots) was increased
to above 2000 mV (green histogram). Following 30 min stimulation
with VEGF, the intensity of 33 ﬂuorescent spots from one cell was fur-
ther increased, and 5% of the ﬂuorescent spots showed intensities as
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(red histogram) was lower than the 10min stimulation. In contrast, the
ﬂuorescence intensity of CD29 in both the control group (one cell, 151
ﬂuorescent spots) and the 10 min VEGF stimulation group (two cells,
176 ﬂuorescent spots) was lower than 3000 mV and there were no
signiﬁcant changes between the two groups. This indicates that CD29
aggregation is not obvious and that there is only a subtle increase in
the intensity of ﬂuorescent spots after 10 min (Fig. 4dH). After 30 min
stimulation with VEGF, the intensity of ﬂuorescent CD29 spots (two
cells, 101 ﬂuorescent spots) increased rapidly and 5% of ﬂuorescent
spots reached 5000 mV in intensity. Together, these ﬁndings suggest
that CD44 molecules ﬁrst assemble the nano-domain, followed by
CD29 nano-domain formation. These changes at the molecular level
may contribute to the directional migration of MSCs.
3.4. Focal adhesion formation and morphological changes of MSCs induced
by VEGF
Focal adhesion formation is an essential step during cell adhesion
and migration. To investigate the underlying mechanism of focal
adhesion formation on cell adhesion and migration induced by VEGF,
immunoﬂuorescence labeling was used to examine the effect of VEGF
on the distribution and expression level of FAK, a major component of
focal adhesions. Fig. 5a shows the immunoﬂuorescence images and
quantitative expression of FAK as measured by LSCM and ﬂowFig. 5. a. FAK (labeledwith Rhodamine anti-human FAK) as imaged by LSCM and FCM. A–D, LSC
MSCs. E, Quantiﬁcation of mean ﬂuorescence intensity (MFI) of FAK in the control group and th
experiments. Arrows indicate FAK aggregation. b. AFM topographical images of cell-surface ultr
VEGF-inducedMSCs. (A, C) 2-D images of thewhole cells; (B, D) 2-D images of cell-surface areas
pseudopodia on theMSCs (dotted boxes). (E), Comparison of the ultra-structural parameters (R
roughness and root-mean-square roughness in the analytical area, respectively. All parameterscytometry. The ﬂuorescence intensity data from LSCM images show
that, following VEGF stimulation, FAK expression increased and
appeared to aggregate (Fig. 5aC, D). Simultaneously, quantitative data
from ﬂow cytometry (Fig. 5aE) also indicated that the mean ﬂuores-
cence intensity (MFI) of FAK increased from the control group of
900 ± 120 to 1500 ± 205 in MSCs upon VEGF treatment.
Under both phase contrast microscope and NSOM, MSCs were ob-
served to acquire an elongated spindle-like shape, while cell adhesion
molecules on MSCs formed clusters upon treatment with VEGF. To
obtain more subtle morphological data, high-resolution AFM was
used. In each group, more than 10 cells were analyzed and measured
by AFM at the cell periphery. As shown in Fig. 5b, there were abundant
pseudopodia among the VEGF-induced MSCs (Fig. 5bC), which may
play a role in intracellular communication andmigration.We also com-
pared average roughness (Ra) and root-mean-square roughness (Rq) in
the analytical area between the control and VEGF-treated groups
(Fig. 5bE). Ra and Rq are an evaluation of the smooth degree of cell
membrane. The roughness calculation of a cell surface provides novel
information regarding to the effect of external stimulation on mem-
brane topography. The topography of 1 μm × 1 μmmembrane surface
in the control group was shown in Fig. 5bB. By analysis, the values of
Ra and Rq were 7.5 nm ± 1.0 nm and 6.2 nm ± 0.8 nm, respectively.
After being treated with VEGF for 24 h (Fig. 5bD), both of them in-
creased to 12.2 nm ± 1.5 nm (Rq) and 9.2 nm ± 1.2 nm (Ra). It
would appear that as the expression and co-localization of CD29 andMimages of FAK distribution. (A, B) are the controlMSCs and (C, D) are 24 h VEGF-induced
e VEGF-induced group. The data were expressed as mean ± S.D. from three independent
a-structures inMSCs treatedwith orwithout VEGF. (A, B) Control MSCs and (C, D) 24 hour
(1 μm× μm)were enlarged from the corresponding cells on the left panel. There aremany
q, Ra) between the control group and the VEGF-induced group. Ra and Rq are the average
were directly generated by the software IP2.1 using 10 cells for each group.
865C. Ke et al. / Biochimica et Biophysica Acta 1848 (2015) 859–868CD44 increase at the surface of MSCs, the surface particles turned into
large.3.5. Cytoskeletal rearrangement with VEGF stimulation
To determine whether the cell movement we observed is due to cy-
toskeletal rearrangements, we analyzed the cellular distribution of actin
by an invertedmicroscope (Fig. 6a) and by LCSM (Fig. 6b). Fluorescence
imaging of the cytoskeleton indicated that the actin in controlMSCswas
disordered (Fig. 6aA and Fig. 6bA, C), while actin in VEGF stimulated
cells showed an elongated spindle shape (Fig. 6aB) and enlarged regions
showed well-organized cytoskeletal alignment directed toward a spe-
ciﬁc orientation (Fig. 6bB, D). These results further conﬁrm that directed
migration in MSCs is associated with cytoskeletal rearrangements.3.6. VEGF treatment enhanced the migration of MSCs
To further conﬁrm the ability of VEGF to induce the migration of
MSCs, we performed simulated wound healing assays. After making
thewound by scratching the surface of the cell culture, MSCswere incu-
batedwith orwithout VEGF for 0, 1, 6, 12, or 24 h before theywere eval-
uated for their ability to migrate into the wound area using an inverted
microscope. Fig. 7a shows images from the wound healing experiment.
The histogram in Fig. 7b shows the number of migrated cells after treat-
mentwith VEGF at different times. These data indicate that VEGF signif-
icantly enhanced the migration of MSCs.Fig. 6. Fluorescencemicroscopyof phalloidin staining. A and C, The representativenonaligned ac
ture in the presence of VEGF with detail picture (D). a and b are respectively obtained by a com4. Discussion
Cells use cell surface receptors to acquire information about and to
respond to their environments. Cell surface molecules regulate many
essential cellular processes, including cell adhesion, tissue development,
cellular communication, inﬂammation, tumor metastasis, and re-
sponses tomicrobial infection. These events often involvemultimolecu-
lar interactions that take place on a nanometer scale and at very high
local concentrations. Therefore, understanding molecular localization
on a single-molecule scale, and its assemblies and interactions on the
cell surface is an important challenge that can be difﬁcult to address be-
cause of the lack of high-resolution single-molecule imaging
techniques.
To our knowledge, the NSOM/QD-based imaging system generates
the best optical resolution (50 nm) for immunoﬂuorescence imaging
of molecules on the cell surface. In this study, we used a NSOM/QD-
based imaging system to directly image the spatial relationship be-
tween CD44 and CD29 on MSCs before and after stimulation with
VEGF. Although confocal microscopy showed that the expression levels
of CD44 and CD29 increased upon VEGF stimulation for 24 h, leading to
the formation of some aggregates on the cell membrane, the technique
was not able to produce nanometer-scale information regardingwheth-
er and how these molecules are distributed on the cell membrane and
whether they share the same space. Most importantly, there were no
obvious changes that could be detected by LSCM during a short period
of stimulation. On the other hand, theNSOM/QD-based nanoscale imag-
ing system allowed us to directly visualize the changes ofmolecular dis-
tribution and organization on the membrane of MSCs.tion structure under control conditionswith detail picture (C); B andD, Aligned actin struc-
mon inverted ﬂuorescence microscope (20×) and a laser confocal scanning microscope.
Fig. 7. Wound and healing assay with a conﬂuent monolayer of mesenchymal stem cells. (A–F): After scratching, the surrounding cells migrated into the scratched area (time after
scratching is indicated). (G) Histogram of the number of migrated cells in control and VEGF group at different times. (A–C) The control group; (D–F) VEGF-induced group.
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tion of CD44 and CD29, nanostructures of both molecules were classi-
ﬁed based on their organization and their apparent size by
immunoﬂuorescence: (i) nano-clusters, b200 nm, (ii) nano-domains,
N200 but b500 nm, and (iii) micro-domains, N500 nm. The scale is
adapted from Chen et al. [35]. To our surprise, both the analyses of in-
tensity and size conﬁrmed that over 30% of CD44 molecules rapidly
form nano-domains that increased signiﬁcantly in size from 200 nm to
295 nm and that increased signiﬁcantly in intensity from below
2000 mV to above 2000 mV. These changes were clearly observed by
NSOM as early as 10 min after VEGF stimulation. As the time of VEGF
stimulation was increased, some of the CD44 molecules even formed
micro-domains. This phenomenon was also conﬁrmed by results
obtained by LSCM (Fig. 4).
Cell surface CD44 glycoproteins bind to HA and other glycosamino-
glycans and mediate cell adhesion to and migration through the extra-
cellular matrix. Through its interaction with proteins that bind to actin
microﬁlaments, CD44 serves as a linkage that transmits signals from
the cell surface to the cytoplasm. In many of these events, the engage-
ment of CD44 induces lipid raft reorganization, which has been
suggested to promote the formation of specialized membrane micro-
domains containing multiple signaling molecules assembled in
complexes that promote the efﬁcient transduction of sustained signals.
In addition, CD44 acts as the co-receptor of VEGFR-2, which plays an
important role in mediating intracellular signal transduction [30]. It
has been reported that hMSCs express VEGFR-2 abundantly and sta-
bly [26]. Our results support the idea that once VEGF is bound to
VEGFR-2 on MSCs, CD44 molecules are activated by VEGF, whichhelps further induce lipid raft reorganization to form larger area
lipid rafts. In turn, CD44 molecules located in lipid rafts become
part of the larger aggregation. Although similar reports indicate
that binding-induced lateral redistribution of CD44 into lipid rafts
can be clearly observed as early as 30 min after Ab-mediated cross-
linking [29], our results show that these changes take place much
sooner than reported.
Our NSOM imaging clearly shows that the VEGF-induced activation
of CD29 takes place after the activation of CD44, which was shown by
an increase in ﬂuorescence intensity and dot size of CD29 molecules
when VEGF stimulation was increased to 30 min. Our model for this
ﬁnding is as follows. Firstly, VEGF exerts its effects by binding to the re-
ceptor tyrosine kinase VEGFR-2. Tyrosine phosphorylation of VEGFR-2
at residue Y951 facilitates the binding of VEGFR-2 to the Rous sarcoma
(Src) homology 2-domain of the T cell-speciﬁc adaptor (TSAD), which
in turn regulates VEGF-induced activation of the c-Src tyrosine kinase
[40]. Then, CD44molecules, acting as co-receptors of VEGFR-2, are acti-
vated by VEGF and further induce lipid raft reorganization to form the
larger area lipid rafts. This results in the recruitment of more Src to
the lipid raft [29]. Finally, integrin (CD29) aggregation is most likely
promoted by a combination of Src and CD29, as Src family molecules
are one of the ligands of integrins. Most importantly, there is an in-
creased amount of co-localization between CD44 and CD29 after VEGF
stimulation for 30 min, which further suggests that both CD44 and
CD29 are located in the newly formed lipid rafts. CD44–Src is brought
within close proximity to integrins and triggers integrin activation.
The perturbation of the lipid bilayer and associatedmembrane proteins
during receptor engagement may facilitate the formation of larger raft
867C. Ke et al. / Biochimica et Biophysica Acta 1848 (2015) 859–868structures with longer half-lives, similar to that which is found in T-cell
immunological synapses. All of these changes involving the cell mem-
brane were detected by AFM (Fig. 5b). Our ultra-structural images
found that the membrane in the control group was much smoother
than in the VEGF-induced group.
Focal adhesion kinase (FAK) is a crucial signaling component that is
activated by numerous stimuli and functions as a biosensor or integra-
tor to control cell motility [41,42]. FAK can inﬂuence the cytoskeletal
structures of cell adhesion sites and membrane protrusions to regulate
cell movement [43,44]. Therefore, observing the effects of VEGF on
FAK may be very important for understanding the underlying mecha-
nisms behind MSC migration. Our results indicate that the level of FAK
expression was not only increased, but that FAK also formed aggrega-
tions on the cell membrane following VEGF stimulation (Fig. 5a). FAK
phosphorylates Cdc42-activated N-WASP at Tyr256, and causes phos-
phorylated N-WASP to remain in the cytoplasm where it can affect
ARP2/3-mediated actin polymerization. Through associations with
Rho GTPase-activating proteins (GAPs) and Rho guanine nucleotide-
exchange factors (GEFs), FAK can regulate actomyosin stress ﬁberFig. 8. A possible mechanism interaction between VEGF, CD44, apolymerization [44]. In our study, the VEGF-induced morphological
changes in cell shape that we observed, such as cell elongation,
ﬁlopodium generation, and cytoskeletal rearrangement are essential
for cell migration, indicating that VEGF has signiﬁcant positive effects
on the migration of MSCs.
Taken together, based on our NSOM imaging analysis and literature
search,we infer that themigration ofMSCs toward tumor sites or region
of myocardial infarction is closely associated with the interaction
between VEGF and the activation of MSCs (Fig. 8). Although other ex-
periments including immunoblotting and co-immunoprecipitation
must be performed to further conﬁrm our inference, the NSOM/QD-
based imaging technique, with its diffraction-unlimited spatial resolu-
tion, has shed new light on the relationship betweenmolecular localiza-
tion and function and has provided us with detailed insights into the
mechanisms of VEGF-induced cell adhesion molecule interactions at
the molecule level. Indeed, NSOM is a powerful, sensitive tool with
which the distribution of single molecules on cell surfaces can be im-
aged, providing new insight into the highly sophisticated functions of
cell surface molecules.nd CD29 obtained from NSOM imaging and LSCM analyses.
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